Brandt v. Wand Partners

242 F.3d 6
Procedural entryThis page is a short order in Brandt v. Wand Partners. Read the opinion of the Court — 242 F.3d 6
Court of Appeals for the First Circuit·Decided August 1, 2001·No. 00-1065·Published

Opinion

242 F.3d 6 (1st Cir. 2001)

WILLIAM A. BRANDT, JR., Plaintiff, Appellant,
v.
WAND PARTNERS, ET AL., Defendants, Appellees.

No. 00-1065

United States Court of Appeals For the First Circuit

Heard October 4, 2000
Decided March 2, 2001
Amended August 1, 2001

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Nathaniel M. Gorton, U.S. District Judge][Copyrighted Material Omitted]

J. Joseph Bainton with whom John G. McCarthy, Ethan D. Siegel, Andrew H. Beatty, Bainton McCarthy & Siegel, LLC, Timothy P. Wickstrom, Tashjian, Simsarian & Wickstrom, Daniel C. Cohn, David Madoff and Cohn & Kelakos LLP were on brief for plaintiff.

John O. Mirick with whom Mirick, O'Connell, De Mallie & Lougee, LLP, David L. Evans, Hanify & King, P.C., Mike McKool, Jr., Sam F. Baxter, Jeffrey A. Carter, Rosemary T. Snider, Randy J. Carter and McKool Smith, P.C. were on brief for appellees Hicks, Muse and Company (TX) Incorporated, Hicks, Muse Equity Fund, L.P., HMC Partners, L.P., HMC Partners, Healthco Holding Corporation, Thomas Hicks, John Muse and Jack Furst.

John J. Curtin, Jr. with whom Mark W. Batten, Bingham, Dana LLP, Matthew Gluck, Gregg L. Weiner, and Fried, Frank, Harris, Shriver & Jacobson, P.C. were on brief for appellees Thomas L. Kempner and Vincent A. Mai.

Thomas G. Rafferty with whom David R. Marriott, Aviva O. Wertheimer, Cravath, Swaine & Moore, Arnold P. Messing, E. Kenly Ames and Choate, Hall & Stewart were on brief for appellee Lazard Freres & Company LLC.

Alan Kolod with whom Mark N. Parry, Moses & Singer LLP, Vincent M. Amoroso and Posternak, Blankstein & Lund were on brief for appellees Kenneth W. Aitchison, Robert E. Mulcahy III, Arthur M. Goldberg and Gemini Partners, L.P.

E. Randolph Tucker with whom John A.D. Gilmore, John A.E. Pottow and Hill & Barlow, P.C. were on brief for The Airlie Group, L.P., Dort Cameron, III, EDB, L.P., TMT-FW, Inc., Thomas M. Taylor, Lee M. Bass and Perry R. Bass.

Thomas C. Frongillo, Brian E. Pastuszenski, Amanda J. Metts and Testa, Hurwitz & Thibeault, LLP on brief for appellees Wand Partners and Mercury Asset Management.

Leonard H. Freiman, James F. Wallack and Goulston & Storrs, P.C. on brief for appellees Helen Cyker and J. Robert Casey, Trustee.

Nancy L. Lazar, Dennis E. Glazer, Edward P. Boyle and Davis Polk and Wardwell on brief for appellee J.P. Morgan & Company, Inc.

Paula M. Bagger, Marjorie Sommer Cooke, Christopher T. Vrountas and Cooke, Clancy & Gruenthal on brief for appellee Marvin Meyer Cyker.

Edwin G. Schallert, Eileen E. Sullivan and Debevoise & Plimpton on brief for appellees Chancellor Capital Management, Inc. and Chancellor Trust Company.

Kathleen S. Donius, Stephen T. Jacobs and Reinhart, Boerner, Van Deuren, Norris & Rieselbach, s.c. on brief for appellee Valuation Research Corporation.

Before Boudin, Circuit Judge, Cyr, Senior Circuit Judge, and Zobel,* District Judge.

BOUDIN, Circuit Judge.

This case arises out of the failure and chapter 7 bankruptcy of Healthco International, Inc. ("Healthco"), a major global distributor of dental products and services. Following this debacle, the chapter 7 trustee brought the present case on behalf of the estate against numerous parties alleged to have been responsible for, or beneficiaries of, the leveraged buyout that precipitated the collapse of Healthco. We begin with a short history of the transactions and proceedings, and then address the claims on appeal made by the bankruptcy trustee, William Brandt.1

I. Factual Background

In the late spring of 1990, Gemini Partners, L.P., a Delaware limited partnership that owned 9.96% of Healthco's common shares, formed the Committee for Maximizing Shareholder Value of Healthco International ("the Committee") and began a proxy contest to remove Healthco's incumbent directors. In response, Healthco engaged Lazard Freres & Co. LLC as its financial advisor and sought to arrange the company's sale to another buyer.

On September 4, 1990, Healthco entered into a merger agreement with affiliates of Hicks, Muse & Co. ("Hicks, Muse"), a Dallas-based investment firm. Under the agreement, a company formed by Hicks, Muse would merge with Healthco after acquiring its stock at a price of $19.25 per share. After reaching this agreement, in mid-September Healthco negotiated a separate settlement agreement with Gemini and the Committee, under which three Committee nominees became members of Healthco's seven-member board. The settlement agreement provided that, if the merger agreement was terminated or sufficient progress toward a sale of the company was not subsequently made, the Committee could increase its share of the board from three out of seven to five out of nine. As a further spur to a merger or sale, Gemini promised each Committee director $24,000, less director compensation, if Gemini sold its shares at a profit.

In February 1991, Hicks, Muse's initial plan for a leveraged buyout2 ("LBO") of Healthco fell apart after Healthco's annual physical inventory indicated that the company's unaudited 1990 earnings were several million dollars lower than expected. Healthco's auditors, Coopers & Lybrand L.L.P., later certified financial statements that revealed a 1990 net loss of just over $5 million and 1990 earnings of less than $22 million. Given such figures, Hicks, Muse determined the $19.25 share price was too high, and the parties set to work drawing up a new plan.

On March 26, 1991, Healthco's board voted 5-2 to approve a new merger plan involving Hicks, Muse affiliates. Marvin Cyker, Healthco's chief executive officer and board chairman, who held stock options but no outstanding shares in Healthco, was one of the two board members who voted against the transaction. The proposal was for a tender offer for Healthco stock at $15 per share to be made under Hicks, Muse's auspices, with financing by other parties, after which Healthco would merge with a new entity controlled by the new investors. Lazard Freres advised that the transaction was fair to Healthco stockholders.

On April 2, a tender offer for Healthco stock was made by HMD Acquisition Corp., a wholly-owned subsidiary of Healthco Holding Co.; Healthco Holding was itself a company set up by Hicks, Muse to be the recipient of $55 million of the Hicks, Muse investors' funds. Additional funds for the merger were to be supplied by a bank group that would provide a $50 million tender facility (i.e., an available loan) in exchange for perfected first priority liens on HMD Acquisition's shares in Healthco. Another group of investment entities were to provide $45 million in cash, in exchange for subordinated debt.

The tender offer was successful. HMD Acquisition acquired more than 90% of Healthco's stock in the tender offer.

Free access — add to your briefcase to read the full text and ask questions with AI

Brandt v. Wand Partners, 242 F.3d 6 (1st Cir. 2001).

242 F.3d 6 (Brandt v. Wand Partners) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Commodity Futures Trading Commission v. Schor
478 U.S. 833 (Supreme Court, 1986)
TRUE v. United States
190 F.3d 1165 (Tenth Circuit, 1999)
Fernandez v. Corporacion Insular De Seguros
79 F.3d 207 (First Circuit, 1996)
Conde v. Starlight I, Inc.
103 F.3d 210 (First Circuit, 1997)
Hicks, Muse & Co. v. Brandt
136 F.3d 45 (First Circuit, 1998)
Brandt v. Wand Partners
242 F.3d 6 (First Circuit, 2001)
United States v. Joseph MacCini
721 F.2d 840 (First Circuit, 1983)
John Borges v. Our Lady of the Sea Corp.
935 F.2d 436 (First Circuit, 1991)
Juan Rivera-Muriente v. Juan Agosto-Alicea
959 F.2d 349 (First Circuit, 1992)
Kirk v. Raymark Industries, Inc.
61 F.3d 147 (Third Circuit, 1995)
Marketa Wills v. Brown University
184 F.3d 20 (First Circuit, 1999)